Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Advanced Research LLC, Deerfield Beach, Florida Erie Retina Research, LLC, Erie, Pennsylvania Retina Consultants of Texas Research Centers, Bellaire, Texas Retina Consultants of America, Southlake, Texas Gundersen Health System, La Crosse, Wisconsin